Antares Pharma, Inc. to Present at Rodman & Renshaw 11th Annual Healthcare Conference

Antares Pharma, Inc. (NYSE Amex: AIS) today announced that Dr. Paul K Wotton, Ph.D., President and Chief Executive Officer, will present at the Rodman & Renshaw 11th Annual Healthcare Conference on Thursday, September 10, 2009 at 11:40 am ET (Eastern Time). The conference will be held at the New York Palace Hotel in New York City.

About Antares Pharma (www.antarespharma.com)

Antares Pharma is a product development company committed to improving pharmaceuticals through its patented drug delivery systems. Antares has multiple development partnerships with leading pharmaceutical companies. The Company’s products are designed to improve safety and efficacy profiles by minimizing dosing and reducing side effects while enabling improved patient compliance. Antares has three validated drug delivery systems: the ATDTM Advanced Transdermal Gel Delivery system, injection technology platforms including both VibexTM disposable pressure assisted auto injectors and Vision® reusable needle-free injectors; and Easy TecTM oral disintegrating tablets (ODT). Two of the systems have generated FDA approved products. Antares Pharma leverages its multiple drug delivery systems to add value to existing drugs and to create new products. Antares Pharma has corporate headquarters in Ewing, New Jersey, with subsidiaries performing research, development, manufacturing and product commercialization activities in Minneapolis, Minnesota and Basel, Switzerland.